<?xml version="1.0" encoding="UTF-8"?>
<p>Our case demonstrates that pseudoprogression can occur at any time during immunotherapy and that clinicians need to pay special attention to identifying it. Characterizing the relationship between pseudoprogression and long-term survival requires longer term, large sample size observations.</p>
